Skip to main content
. 2020 Sep 15;40(1):50–58. doi: 10.12938/bmfh.2020-046

Table 3. Characteristics of NAFLD patients according to microbiota diversity index (OTU, Shannon-Weaver Index, and Simpson’s Diversity Index).

OTU p value Shannon-Weaver Index P value Simpson Diversity Index p value
Fibrosis
Non Significant 155 (90–331) 0.141 3.94 (1.63–5.43) 0.245 0.88 (0.38–0.95) 0.473
Significant 190 (101–296) 4.39 (2.93–5.59) 0.90 (0.76–0.96)
Steatosis
Non Significant 155 (93–331) 0.808 3.94 (1.63–5.33) 0.447 0.86 (0.38–0.95) 0.213
Significant 177 (90–269) 4.22 (2.58–5.59) 0.90 (0.75–0.96)
BMI
Non Obese 177 (99–331) 0.527 4.45 (1.63–5.43) 0.183 0.91 (0.38–0.95) 0.080
Obese 176 (90–296) 3.92 (2.31–5.59) 0.87 (0.60–0.96)
Central obesity
No 192 (155–214) 0.404 4.54 (4.06–4.98) 0.221 0.91 (0.88–0.94) 0.266
Yes 176 (90–331) 4.11 (1.63–6.59) 0.88 (0.38–0.96)
Triglyceride
Normal 183 (101–331) 0.010* 4.33 (3.06–5.59) 0.005* 0.91 (0.76–0.96) 0.003*
Increase 118 (90–201) 3.68 (1.63–4.41) 0.83 (0.38–0.90)
HDL
Normal 188 (97–296) 0.158 4.38 (1.63–5.59) 0.064 0.91 (0.38–0.96) 0.114
Decrease 151 (90–331) 3.84 (2.31–5.33) 0.87 (0.60–0.94)
LDL
Normal 169 (106–331) 0.929 4.15 (3.06–5.33) 0.546 0.90 (0.80–0.94) 0.339
Increase 180 (90–296) 4.14 (1.63–5.59) 0.88 (0.38–0.96)
Diabetes mellitus
No 181 (112–220) 0.684 4.06 (3.76–4.96) 0.816 0.88 (0.84–0.95) 0.485
Yes 172 (90–331) 4.18 (1.63–5.59) 0.88 (0.38–0.96)

Data are presented as medians (minimum-maximum). NAFLD: non-alcoholic fatty liver disease; OTU: operational taxonomic unit; BMI: body mass index; HLD: high-density lipoprotein; LDL: low-density lipoprotein. *Statistically significant by Mann-Whitney test.